2021
DOI: 10.3390/neurolint13040061
|View full text |Cite
|
Sign up to set email alerts
|

Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature

Abstract: Background and Purpose: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China in December 2019. Symptoms range from mild flu-like symptoms to more severe presentations, including pneumonia, acute respiratory distress syndrome (ARDS), and even death. In response to the COVID-19 pandemic, the Emergency Use Authorization (EUA) approved the use of several vaccines. Because vaccines have been fast-tracked for emergency use, the short and long-term safety profile h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 47 publications
0
16
0
Order By: Relevance
“…Similarly, another case series found 21 cases of new-onset, or flares of, inflammatory/autoimmune neurological conditions following COVID-19 vaccination, including eight cases of central nervous system demyelination, four cases of inflammatory peripheral neuropathies, and three cases of myositis (Kaulen et al, 2021). Finally, neuroinflammation and demyelination following COVID-19 vaccination have been imaged using MRI (Camera et al, 2021;Kania et al, 2021;Rinaldi et al, 2021;Sriwastava et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, another case series found 21 cases of new-onset, or flares of, inflammatory/autoimmune neurological conditions following COVID-19 vaccination, including eight cases of central nervous system demyelination, four cases of inflammatory peripheral neuropathies, and three cases of myositis (Kaulen et al, 2021). Finally, neuroinflammation and demyelination following COVID-19 vaccination have been imaged using MRI (Camera et al, 2021;Kania et al, 2021;Rinaldi et al, 2021;Sriwastava et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…The PRISMA flowchart ( Figure 1 ) showed a search strategy for our review. The present study consisted of 28 studies, including 26 case reports, one case series, and one cross-sectional, and the pooled data of 31 patients with COVID-19 vaccine-associated ATM is extracted ( Sriwastava et al, 2021 , Sepahvand et al, 2022 , Tan et al, 2021 , Corrêa et al, 2021 , Vegezzi et al, 2021 , Hsiao et al, 2021 , Pagenkopf and Südmeyer, 2021 , Notghi et al, 2021 , Gao et al, 2021 , Malhotra et al, 2021 , Khan et al, 2022 , Erdem et al, 2021 , Hirose et al, 2021 , Tahir et al, 2021 , Miyaue et al, 2021 , Fujikawa et al, 2021 , Kaulen et al, 2022 , McLean and Trefts, 2021 , Alabkal et al, 2021 , Fitzsimmons and Nance, 2021 , Nakano et al, 2022 , Spataro et al, 2022 , Cabral et al, 2022 , Khan et al, 2022 , Maroufi et al, 2022 , Eom et al, 2022 , Netravathi et al, 2022 , Esechie et al, 2022 ). All of the selected studies were written in the English language.…”
Section: Resultsmentioning
confidence: 99%
“…Due to the severity of the COVID-19 pandemic, massive efforts were made to shorten the timing of vaccine development. Neurological problems associated with SARS-CoV-2 vaccinations are rare [ 6 ]. In their comprehensive analysis, Chen et al described various neurological adverse effects associated with routinely available COVID-19 vaccinations [ 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%